SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Cannabics Pharmaceuticals Inc. (CNBX)

Cannabics Pharmaceuticals Announces a New Dosage of 5mg

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
captainscotty Member Profile
Member Level 
Followed By 220
Posts 8,529
Boards Moderated 20
Alias Born 12/15/12
160x600 placeholder
Annual Report (10-k) "Edgar (US Regulatory)" - 12/8/2017 9:21:56 AM
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 11/29/2017 3:38:25 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 3:23:09 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/13/2017 3:21:46 PM
Biotechs Develop Proprietary Systems to Drive CBD Research and Development "NetworkNewsWire" - 10/25/2017 8:45:00 AM
MJAC 2017 Speaker Update - How venture capital and cryptocurrency are converging as the future of cannabis investing "InvestorsHub NewsWire" - 8/30/2017 10:29:33 PM
PotNetwork Holdings, Inc Confirmed for MJAC 2017 "InvestorsHub NewsWire" - 8/28/2017 10:43:55 AM
MJAC 2017 International Cannabis Conference - Discount Code "InvestorsHub NewsWire" - 8/25/2017 6:50:56 PM
Book your ticket now for InvestorsHubs International Cannabis Conference "InvestorsHub NewsWire" - 8/23/2017 12:50:25 PM
MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market "InvestorsHub NewsWire" - 8/22/2017 1:27:13 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 7/17/2017 11:52:07 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/10/2017 7:31:06 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 5/10/2017 7:30:13 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 4/24/2017 6:01:53 AM
What Cannabis Stocks Investors Should Know and Coverage of a Mobile Tech Sub Penny Stock "InvestorsHub NewsWire" - 4/20/2017 9:00:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 4/14/2017 9:36:26 AM
Securities Registration Statement (simplified Form) (s-3/a) "Edgar (US Regulatory)" - 4/7/2017 9:44:22 AM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 3/21/2017 1:18:21 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 3/15/2017 12:52:22 PM
Israeli Innovation is at the Heart of a Growing Cannabis Ecosystem "NetworkNewsWire" - 2/8/2017 8:30:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 1/17/2017 12:03:56 PM
Report of Proposed Sale of Securities (144) "Edgar (US Regulatory)" - 12/21/2016 2:05:02 PM
captainscotty Member Level  Sunday, 01/15/17 09:13:10 PM
Re: None
Post # of 2637 
Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intended for naïve patient who have not tried cannabis in the past.


http://finance.yahoo.com/news/cannabics-pharmaceuticals-announces-dosage-5mg-143000245.html



https://mma.prnewswire.com/media/453148/Cannabics_Pharma.jpg">https://mma.prnewswire.com/media/453148/Cannabics_Pharma.jpg" />


Dr. Eyal Ballan, Chief scientist of Cannabics Pharmaceuticals stated, "Our mission is to find the right balance between efficacy on the one hand and the elimination of undesired psychoactive effects on other."

The Cannabics 5mg THC capsule is currently being evaluated by the company in a clinical study as a palliative treatment, which is conducted by the oncology department at the prestigious Rambam Medical Center in northern Israel and under strict regulations of the Ministry of Health, by whom Cannabics Pharmaceuticals has been licensed since 2014.

The study is taking place in Israel, it is fully registered with the US NIH under "Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients", Identifier NCT02359123, and may be found at https://clinicaltrials.gov/ct2/show/NCT02359123

"The majority of our cancer trial patients have no previous experience with Cannabis, hence this recalibration of the THC level may be more amenable. We believe there is a significant potential medical market for our 5mg THC capsule in countries that have now instituted medical cannabis regulations," said Itamar Borochov, CEO of Cannabics Pharmaceuticals Inc.

About Cannabics Pharmaceuticals Inc.

Cannabics Pharmaceuticals Inc. (CNBX), a U.S based public company, is dedicated to the development of Personalized Anti-Cancer and Palliative treatments. The Company's R&D is based in Israel, where it is licensed by the Ministry of Health for its work in both scientific and clinical research. The Company's focus is on harnessing the therapeutic properties of natural Cannabinoid formulations and diagnostics. Cannabics' vision is to create individually tailored natural therapies for cancer patients, utilizing advanced screening systems and personalized bioinformatics tools.

THE DOT-BONG ECONOMY IS HERE...:-}


\
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (3) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist